Asthma Clinical Research Studies
The purpose of this study is to see how well the combination of FF (Fluticasone Furoate) /VI (Vilanterol) improves asthma symptoms and lung function in patients aged 5 to 17 years compared to using FF alone and to also assess the safety of FF/VI in the participants.
The purpose of this study is to collect information to help us understand how doctors treat and manage people with severe asthma and how the health of people with severe asthma changes with those treatments. In this study, no specific treatment or research drug is given, but your normal care and assessments are recorded. The length of each patient’s participation will vary but the goal is to have patients involved for 3 or more years.
Investigational Inhaler Study
The purpose of this study is to determine if the study medication “PT027”, which is a combination of budesonide and albuterol sulfate given in a metered-dose inhaler is effective and safe for the treatment of asthma symptoms. This investigational drug combination delivers 2 well-established asthma treatments.